These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34445711)

  • 1. Angioedema and Fatty Acids.
    Wada A; Sawada Y; Sugino H; Nakamura M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioedema Due to Bradykinin Dysregulation.
    Cicardi M; Zuraw BL
    J Allergy Clin Immunol Pract; 2018; 6(4):1132-1141. PubMed ID: 30033914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].
    Hahn J; Bas M; Hoffmann TK; Greve J
    HNO; 2015 Dec; 63(12):885-93; quiz 894-5. PubMed ID: 26597136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema.
    Fandaros M; Joseph K; Kaplan AP; Rubenstein DA; Ghebrehiwet B; Yin W
    Inflammation; 2022 Feb; 45(1):116-128. PubMed ID: 34494203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angioedema and the role of bradykinins: new treatments and implications in patients with heart failure].
    Mansi M; Wu MA; Zanichelli A; Cicardi M
    G Ital Cardiol (Rome); 2016 Dec; 17(12):966-972. PubMed ID: 28151501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on bradykinin-mediated angioedema in 2020.
    Lepelley M; Bernardeau C; Defendi F; Crochet J; Mallaret M; Bouillet L
    Therapie; 2020 Apr; 75(2):195-205. PubMed ID: 32113689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of angioedema without urticaria in the emergency department.
    Pedrosa M; Prieto-García A; Sala-Cunill A;
    Ann Med; 2014 Dec; 46(8):607-18. PubMed ID: 25580506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin-mediated angioedema.
    Obtułowicz K
    Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New topics in bradykinin research.
    Maurer M; Bader M; Bas M; Bossi F; Cicardi M; Cugno M; Howarth P; Kaplan A; Kojda G; Leeb-Lundberg F; Lötvall J; Magerl M
    Allergy; 2011 Nov; 66(11):1397-406. PubMed ID: 21859431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.
    Lara-Marquez ML; Christiansen SC; Riedl MA; Herschbach J; Zuraw BL
    Clin Exp Allergy; 2018 Nov; 48(11):1429-1438. PubMed ID: 29957871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
    Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
    Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema.
    Bas M; Kirchhartz N; Hochfeld J; Tüllmann C; Kumpf S; Suvorava T; Oppermann M; Hafner D; Bier H; Hoffmann TK; Balz V; Kojda G
    J Allergy Clin Immunol; 2008 Apr; 121(4):969-75.e2. PubMed ID: 18395553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
    Bartal C; Zeldetz V; Stavi V; Barski L
    Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular reactions in hereditary angioneurotic edema.
    Juhlin L; Michaëlsson G
    Acta Derm Venereol; 1969; 49(1):20-5. PubMed ID: 4182089
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation and Management of Angioedema in the Emergency Department.
    Long BJ; Koyfman A; Gottlieb M
    West J Emerg Med; 2019 Jul; 20(4):587-600. PubMed ID: 31316698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-histaminergic angioedema: focus on bradykinin-mediated angioedema.
    Busse PJ; Buckland MS
    Clin Exp Allergy; 2013 Apr; 43(4):385-94. PubMed ID: 23517034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema as a systemic disease.
    Kazandjieva J; Christoff G
    Clin Dermatol; 2019; 37(6):636-643. PubMed ID: 31864442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future therapies for the treatment of histamine-induced angioedema.
    James C; Bernstein JA
    Expert Opin Pharmacother; 2017 Feb; 18(3):253-262. PubMed ID: 28081650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.